Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-01-27
DOI
10.1093/jac/dkac023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral Fosfomycin Treatment for Enterococcal Urinary Tract Infections in a Dynamic In Vitro Model
- (2020) Iain J. Abbott et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin plus Fosfomycin versus Daptomycin Alone for Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis. A Randomized Clinical Trial
- (2020) Miquel Pujol et al. CLINICAL INFECTIOUS DISEASES
- A systematic review of central-line–associated bloodstream infection (CLABSI) diagnostic reliability and error
- (2019) Emily N. Larsen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Pharmacodynamics of daptomycin when prescribed in combination with other antibiotics for treatment of enterococcal bacteremia
- (2019) Lindsay M. Avery et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis
- (2018) Cristina García-de-la-Mària et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combatting resistant enterococcal infections: a pharmacotherapy review
- (2018) Nicholas J Mercuro et al. EXPERT OPINION ON PHARMACOTHERAPY
- A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections
- (2018) Yu-Chung Chuang et al. Scientific Reports
- Pharmacodynamic Analysis of Daptomycin-Treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint
- (2018) Lindsay M Avery et al. CLINICAL INFECTIOUS DISEASES
- Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis
- (2017) Anthony M. Casapao et al. PHARMACOTHERAPY
- Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in anIn VitroPharmacokinetic-Pharmacodynamic Model
- (2016) Ashley D. Hall Snyder et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fosfomycin
- (2016) Matthew E. Falagas et al. CLINICAL MICROBIOLOGY REVIEWS
- Vancomycin-Resistant Enterococci
- (2016) William R. Miller et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- β-Lactams Enhance Daptomycin Activity against Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium inIn VitroPharmacokinetic/Pharmacodynamic Models
- (2015) Jordan R. Smith et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic options for vancomycin-resistant enterococcal bacteremia
- (2015) Katie E Barber et al. Expert Review of Anti-Infective Therapy
- Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model
- (2014) A. Hall Snyder et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008–10
- (2013) Jason M Pogue et al. JOURNAL OF ANTIBIOTICS
- Altering the Proclivity towards Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Using Combinations with Other Antibiotics
- (2012) Andrew D. Berti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fosfomycin SynergyIn Vitrowith Amoxicillin, Daptomycin, and Linezolid against Vancomycin-Resistant Enterococcus faecium from Renal Transplant Patients with Infected Urinary Stents
- (2012) Jillian L. Descourouez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The rise of the Enterococcus: beyond vancomycin resistance
- (2012) Cesar A. Arias et al. NATURE REVIEWS MICROBIOLOGY
- Antimicrobial Susceptibilities of Commonly Encountered Bacterial Isolates to Fosfomycin Determined by Agar Dilution and Disk Diffusion Methods
- (2011) Ching-Lan Lu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Daptomycin-Resistant VRE: Experience of a Single Institution
- (2011) Mini Kamboj et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- The revival of fosfomycin
- (2011) Argyris S. Michalopoulos et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Influence of Genospecies of Acinetobacter baumannii Complex on Clinical Outcomes of Patients with Acinetobacter Bacteremia
- (2010) Y.-C. Chuang et al. CLINICAL INFECTIOUS DISEASES
- Adverse events associated with intravenous fosfomycin
- (2010) Amélie Florent et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search